News

As such, the Zacks rating upgrade for Palisade Bio is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company's future ...
To report any concerns or inaccuracies, please contact us at [email protected]. The post PALI Stock Earnings: Palisade Bio Misses EPS for Q2 2024 appeared first on InvestorPlace.